This company seems to have been delisted
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Orchard Therapeutics
ORTX
C$22.91
Share price
0.00%
Change (1 day)
245.38%
Change (1 year)
Orchard Therapeutics (ORTX) - Total assets
Total assets on the balance sheet as of September 2023 : C$0.27 Billion
According to Orchard Therapeutics 's latest financial reports the company's total assets are C$0.27 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Orchard Therapeutics - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | C$0.29 B | -27.71% |
| 2021-12-31 | C$0.41 B | 14.71% |
| 2020-12-31 | C$0.35 B | -31.31% |
| 2019-12-31 | C$0.52 B | 4.59% |
| 2018-12-31 | C$0.49 B | 307.63% |
| 2017-12-31 | C$0.12 B | 2025.24% |
| 2016-12-31 | C$5.75 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | C$1.71 B | 517.41% | Jersey |
 Novavax NVAX | C$1.77 B | 539.25% | 🇺🇸 USA |
 Organovo ONVO | C$20.09 M | -92.76% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | C$0.27 B | 0.00% | 🇬🇧 UK |